Marker Therapeutics, Inc. (MRKR)
NASDAQ·Healthcare·Biotechnology
$1.43
-1.38%
Mkt Cap $15.87M
No analyst coverage available
We don't have analyst ratings or price target data for Marker Therapeutics, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.